| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 13 |
| NetGPI | no | yes: 0, no: 13 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005737 | cytoplasm | 2 | 1 |
| GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9ANG0
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 185 | 189 | PF00656 | 0.545 |
| CLV_NRD_NRD_1 | 122 | 124 | PF00675 | 0.678 |
| CLV_NRD_NRD_1 | 150 | 152 | PF00675 | 0.482 |
| CLV_NRD_NRD_1 | 254 | 256 | PF00675 | 0.347 |
| CLV_PCSK_FUR_1 | 120 | 124 | PF00082 | 0.732 |
| CLV_PCSK_KEX2_1 | 120 | 122 | PF00082 | 0.651 |
| CLV_PCSK_KEX2_1 | 150 | 152 | PF00082 | 0.470 |
| CLV_PCSK_KEX2_1 | 254 | 256 | PF00082 | 0.451 |
| CLV_PCSK_PC1ET2_1 | 150 | 152 | PF00082 | 0.428 |
| CLV_PCSK_SKI1_1 | 152 | 156 | PF00082 | 0.424 |
| CLV_PCSK_SKI1_1 | 255 | 259 | PF00082 | 0.317 |
| DEG_SPOP_SBC_1 | 288 | 292 | PF00917 | 0.552 |
| DOC_CKS1_1 | 132 | 137 | PF01111 | 0.705 |
| DOC_CKS1_1 | 63 | 68 | PF01111 | 0.615 |
| DOC_MAPK_gen_1 | 204 | 214 | PF00069 | 0.343 |
| DOC_PP1_RVXF_1 | 253 | 260 | PF00149 | 0.318 |
| DOC_PP1_RVXF_1 | 264 | 270 | PF00149 | 0.318 |
| DOC_USP7_MATH_1 | 288 | 292 | PF00917 | 0.630 |
| DOC_USP7_UBL2_3 | 200 | 204 | PF12436 | 0.614 |
| DOC_WW_Pin1_4 | 131 | 136 | PF00397 | 0.635 |
| DOC_WW_Pin1_4 | 156 | 161 | PF00397 | 0.460 |
| DOC_WW_Pin1_4 | 62 | 67 | PF00397 | 0.619 |
| DOC_WW_Pin1_4 | 77 | 82 | PF00397 | 0.635 |
| LIG_14-3-3_CanoR_1 | 207 | 212 | PF00244 | 0.343 |
| LIG_14-3-3_CanoR_1 | 23 | 29 | PF00244 | 0.501 |
| LIG_14-3-3_CanoR_1 | 254 | 260 | PF00244 | 0.343 |
| LIG_FHA_1 | 189 | 195 | PF00498 | 0.509 |
| LIG_FHA_1 | 2 | 8 | PF00498 | 0.624 |
| LIG_FHA_1 | 224 | 230 | PF00498 | 0.449 |
| LIG_FHA_1 | 35 | 41 | PF00498 | 0.593 |
| LIG_FHA_2 | 132 | 138 | PF00498 | 0.718 |
| LIG_FHA_2 | 183 | 189 | PF00498 | 0.450 |
| LIG_FHA_2 | 220 | 226 | PF00498 | 0.347 |
| LIG_LIR_Apic_2 | 159 | 165 | PF02991 | 0.426 |
| LIG_LIR_Gen_1 | 258 | 269 | PF02991 | 0.468 |
| LIG_LIR_Nem_3 | 268 | 272 | PF02991 | 0.318 |
| LIG_LIR_Nem_3 | 275 | 280 | PF02991 | 0.318 |
| LIG_PCNA_yPIPBox_3 | 15 | 23 | PF02747 | 0.443 |
| LIG_SH2_NCK_1 | 157 | 161 | PF00017 | 0.557 |
| LIG_SH2_PTP2 | 162 | 165 | PF00017 | 0.420 |
| LIG_SH2_STAP1 | 95 | 99 | PF00017 | 0.568 |
| LIG_SH2_STAT5 | 162 | 165 | PF00017 | 0.420 |
| LIG_SH2_STAT5 | 71 | 74 | PF00017 | 0.757 |
| LIG_SH3_3 | 108 | 114 | PF00018 | 0.688 |
| LIG_SH3_3 | 126 | 132 | PF00018 | 0.707 |
| LIG_SH3_3 | 48 | 54 | PF00018 | 0.648 |
| LIG_SUMO_SIM_par_1 | 210 | 215 | PF11976 | 0.421 |
| LIG_TRAF2_1 | 114 | 117 | PF00917 | 0.672 |
| LIG_TYR_ITIM | 93 | 98 | PF00017 | 0.589 |
| LIG_WRC_WIRS_1 | 277 | 282 | PF05994 | 0.330 |
| LIG_WW_3 | 65 | 69 | PF00397 | 0.738 |
| MOD_CDK_SPxK_1 | 62 | 68 | PF00069 | 0.631 |
| MOD_CK2_1 | 131 | 137 | PF00069 | 0.733 |
| MOD_CK2_1 | 207 | 213 | PF00069 | 0.340 |
| MOD_CK2_1 | 219 | 225 | PF00069 | 0.278 |
| MOD_GlcNHglycan | 15 | 18 | PF01048 | 0.547 |
| MOD_GlcNHglycan | 238 | 241 | PF01048 | 0.441 |
| MOD_GlcNHglycan | 56 | 59 | PF01048 | 0.754 |
| MOD_GlcNHglycan | 77 | 80 | PF01048 | 0.754 |
| MOD_GSK3_1 | 101 | 108 | PF00069 | 0.582 |
| MOD_GSK3_1 | 219 | 226 | PF00069 | 0.472 |
| MOD_GSK3_1 | 82 | 89 | PF00069 | 0.672 |
| MOD_N-GLC_1 | 2 | 7 | PF02516 | 0.658 |
| MOD_N-GLC_1 | 75 | 80 | PF02516 | 0.757 |
| MOD_NEK2_1 | 1 | 6 | PF00069 | 0.622 |
| MOD_NEK2_1 | 212 | 217 | PF00069 | 0.343 |
| MOD_NEK2_1 | 276 | 281 | PF00069 | 0.330 |
| MOD_NEK2_1 | 29 | 34 | PF00069 | 0.570 |
| MOD_NEK2_2 | 260 | 265 | PF00069 | 0.468 |
| MOD_PIKK_1 | 212 | 218 | PF00454 | 0.333 |
| MOD_PK_1 | 105 | 111 | PF00069 | 0.736 |
| MOD_PK_1 | 207 | 213 | PF00069 | 0.451 |
| MOD_PKA_1 | 255 | 261 | PF00069 | 0.318 |
| MOD_PKA_2 | 22 | 28 | PF00069 | 0.589 |
| MOD_Plk_1 | 2 | 8 | PF00069 | 0.654 |
| MOD_Plk_1 | 212 | 218 | PF00069 | 0.343 |
| MOD_Plk_4 | 2 | 8 | PF00069 | 0.626 |
| MOD_Plk_4 | 207 | 213 | PF00069 | 0.394 |
| MOD_Plk_4 | 255 | 261 | PF00069 | 0.339 |
| MOD_ProDKin_1 | 131 | 137 | PF00069 | 0.635 |
| MOD_ProDKin_1 | 156 | 162 | PF00069 | 0.464 |
| MOD_ProDKin_1 | 62 | 68 | PF00069 | 0.622 |
| MOD_ProDKin_1 | 77 | 83 | PF00069 | 0.636 |
| TRG_DiLeu_BaEn_1 | 177 | 182 | PF01217 | 0.413 |
| TRG_ENDOCYTIC_2 | 261 | 264 | PF00928 | 0.438 |
| TRG_ENDOCYTIC_2 | 277 | 280 | PF00928 | 0.206 |
| TRG_ENDOCYTIC_2 | 95 | 98 | PF00928 | 0.573 |
| TRG_ER_diArg_1 | 120 | 123 | PF00400 | 0.652 |
| TRG_ER_diArg_1 | 151 | 154 | PF00400 | 0.432 |
| TRG_ER_diArg_1 | 280 | 283 | PF00400 | 0.327 |
| TRG_NES_CRM1_1 | 39 | 50 | PF08389 | 0.663 |
| TRG_NLS_MonoCore_2 | 149 | 154 | PF00514 | 0.437 |
| TRG_NLS_MonoExtN_4 | 150 | 155 | PF00514 | 0.438 |
| TRG_Pf-PMV_PEXEL_1 | 153 | 158 | PF00026 | 0.433 |
| TRG_Pf-PMV_PEXEL_1 | 270 | 275 | PF00026 | 0.330 |
| TRG_Pf-PMV_PEXEL_1 | 41 | 45 | PF00026 | 0.615 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P8D9 | Leptomonas seymouri | 35% | 100% |
| A0A0N1PAZ1 | Leptomonas seymouri | 84% | 100% |
| A0A0S4JV55 | Bodo saltans | 50% | 87% |
| A0A1X0NWX9 | Trypanosomatidae | 57% | 97% |
| A0A3Q8I8Y8 | Leishmania donovani | 98% | 100% |
| A0A3S5ISC8 | Trypanosoma rangeli | 52% | 97% |
| A4H9U4 | Leishmania braziliensis | 92% | 100% |
| A4HUS6 | Leishmania infantum | 98% | 100% |
| D0A7N8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 49% | 93% |
| Q4QH66 | Leishmania major | 97% | 100% |
| V5BB20 | Trypanosoma cruzi | 56% | 97% |
| V5DLK4 | Trypanosoma cruzi | 51% | 66% |